scispace - formally typeset
Open AccessJournal ArticleDOI

Diabetes and Ramadan: Practical guidelines.

Reads0
Chats0
TLDR
The IDF-DAR Practical Guidelines should enhance knowledge surrounding the issue of diabetes and Ramadan fasting, thereby empowering healthcare professionals to give the most up-to-date advice and the best possible support to their patients during Ramadan.
About
This article is published in Diabetes Research and Clinical Practice.The article was published on 2017-04-01 and is currently open access. It has received 247 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Achieving safer Ramadan fasting by keeping flexible glycemic targets during the day and tighter targets during the night in insulin treated people with type 2 diabetes

TL;DR: By keeping flexible glycemic targets during the day and tighter targets During the night, safe fasting was feasible with significant improvement in overall glycemic control without the development of major complications in insulin-treated people with type 2 diabetes during Ramadan.
Journal ArticleDOI

Impact of religious fasting on metabolic and hematological profile in both dyslipidemic and non-dyslipidemic fasters.

TL;DR: In this paper, the impact of religious fasting on the metabolic and hematological profiles of individuals with or without dyslipidemia was investigated. And the results showed that a significant reduction of fasting glucose, HDL, LDL, and TC levels was found post-RF, while vitamin B12 and calcium levels were substantially decreased.
Journal ArticleDOI

Fructosamine as an Index of Short-Term Glycemic Control in Pregnant Women with Diabetes: Before, During and After Ramadan

TL;DR: In this paper , a prospective observational study was conducted to investigate the impact of fasting on pregnant women with diabetes and found that the mean fructosamine level decreased during and after ramadan in gestation diabetes pregnant women compared to type 2 diabetes and type 1 diabetes pregnant people.
Journal ArticleDOI

The effect of COVID-19 on Ramadan fasting in people with diabetes in East London 2020: The East London diabetes in Ramadan survey.

TL;DR: COVID-19 had an impact on people with diabetes and their fasting intentions during Ramadan 2020; most people who were advised not to fast did not fast; there were few adverse outcomes from fasting.
References
More filters
Journal ArticleDOI

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

TL;DR: Clinical trials with the incretin mimetic exenatide and liraglutide show reductions in fasting and postprandial glucose concentrations, and haemoglobin A1c (HbA1c) associated with weight loss, but long-term clinical studies are needed to determine the benefits of targeting the inc retin axis for the treatment of type 2 diabetes.
Journal ArticleDOI

Impact of sleep debt on metabolic and endocrine function

TL;DR: Sleep debt has a harmful impact on carbohydrate metabolism and endocrine function similar to those seen in normal ageing and, therefore, sleep debt may increase the severity of age-related chronic disorders.
Journal ArticleDOI

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.

TL;DR: Careful postmarketing surveillance for adverse effects, especially among the DPP4 inhibitors, and continued evaluation in longer-term studies and in clinical practice are required to determine the role of this new class of pharmacotherapies for type 2 diabetes.
Journal ArticleDOI

A Population-Based Study of Diabetes and Its Characteristics During the Fasting Month of Ramadan in 13 Countries Results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study

TL;DR: There is a need to provide more intensive education before fasting, to disseminate guidelines, and to propose further studies assessing the impact of fasting on morbidity and mortality.
Journal ArticleDOI

Adiponectin: action, regulation and association to insulin sensitivity

TL;DR: Adiponectin in addition to possible anti‐inflammatory and anti‐atherogenic effects appears to be an insulin enhancer, with potential as a new pharmacologic treatment modality of the metabolic syndrome and type 2 diabetes.
Related Papers (5)